Clinical Trials on Polyphenolic Compounds and Metabolism

Total 54240 results

Hospices Civils de Lyon

Recruiting

From Known to New Genes in Dyslipidemia (GENELIP)

Dyslipidemias

France
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391

Dyslipidemias

Korea, Republic of
Amgen

Completed

Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk Open-label Extension (FOURIER OLE)

Dyslipidemia

United States, Poland, Czechia, Hungary, Russian Federation, Ukraine, Slovakia
Abbott

Completed

A Clinical Study to Evaluate the Effect of Mobile Applications "My A:Care" and "Smart Coach" on the Lipid-lowering Treatment Adherence of Subjects With Dyslipidemia in Thailand (My A:Care)

Dyslipidemia

Thailand
Sun Yat-sen University

Completed

A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder

Dyslipidemias

China
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms

Fat Disorder

United States
Eli Lilly and Company

Completed

A Study of LY3561774 in Participants With Dyslipidemia

Dyslipidemias

United States
Kowa Company, Ltd.

Completed

A Phase III Long Term Study of K-877 Extended Release Tablet

Dyslipidemias

Japan
Dr. Anatoly Langer
Amgen

Active, not recruiting

GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL (GOAL QuERI)

Dyslipidemia

Kuwait, Mexico, Saudi Arabia, United Arab Emirates
Laboratorios Silanes S.A. de C.V.

Completed

Study to Evaluate the Safety of the Fixed-dose Combination Rosuvastatin/Ezetimibe for Patients With Dyslipidaemia (TREZETE)

Dyslipidemias

Mexico
Organon and Co

Completed

Retrospective Survey Evaluating the Effectiveness and Safety of Dual Inhibition Lipid-lowering in the Treatment of Dyslipidemia (Study P05171)(COMPLETED)

Dyslipidemia
BTL Industries Ltd.

Completed

Non-invasive Lipolysis and Improvement of Muscle Tone in Inner Thighs

Fat Disorder

United States
Yooyoung Pharmaceutical Co., Ltd.

Completed

Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A

Dyslipidemias

Korea, Republic of
University of Colorado, Denver
American Society of Health-System Pharmacists

Withdrawn

Glucose Variability in Cancer Patients Receiving Dexamethasone

Hyperglycemia | Cancer

United States
Abbott

Completed

Post Marketing Surveillance of Safety and Efficacy for Cholib in Korean Patients Under the "New Drug Re-examination".

Dyslipidemias

Korea, Republic of
Sun Yat-sen University

Completed

Dietary Anthocyanins Improve Lipid Metabolism in a Dose - Dependent Manner

Dyslipidemias

China
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI); Arizona Pharmaceuticals...

Completed

Effects of Niacin On Fatty Acid Trapping (NOFAT)

Dyslipidemia

United States
Veloxis Pharmaceuticals

Completed

12-Month, Open-Label, Extension Study of LCP-AtorFen in Dyslipidemia

Dyslipidemia

United States
Canadian Heart Research Centre
Amgen

Completed

Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada (GOAL)

Dyslipidemia
University of Minnesota
Laval University

Completed

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia (FPI)

Dyslipidemia

United States
Aga Khan University
Muhammad Safdar Ali

Unknown

Effect of Aerobic Training and Moringa Oleifera on Dyslipidemia and Cardiac Endurance

Dyslipidemias
NorthSea Therapeutics B.V.

Completed

A Study to Evaluate the Effects of NST-4016 on QT/Corrected QT (QTc) Interval

Dyslipidemias

United Kingdom
Children's Mercy Hospital Kansas City

Completed

Pharmacokinetics of Rosuvastatin and Atorvastatin in Pediatric Dyslipidemia Patients (SD2)

Dyslipidemia

United States
Kathryn Beardsall

Completed

Point of Care Ketone Measurement in the Newborn (POCKET)

Hypoglycaemia

United Kingdom
Uppsala University

Completed

Fatty Acid Biomarkers of Carbohydrate Intake (CARBIO)

Dyslipidemias

Sweden
Eli Lilly and Company

Completed

A Study of Evacetrapib in Participants With Abnormal Cholesterol

Dyslipidemia

United States
Shaheed Zulfiqar Ali Bhutto Medical University

Unknown

Effect of Adding Folic Acid on Lipid Parameters in Population With Dyslipidemias

Dyslipidemias

Pakistan
Amgen

Completed

Evaluating PCSK9 Binding antiBody Influence oN coGnitive HeAlth in High cardiovascUlar Risk Subjects (EBBINGHAUS)

Dyslipidemia

United States, Belgium, Denmark, Finland, France, Italy, Spain, Hungary, Poland, Germany, Czechia, Turkey, United Kingdom, Malaysia, Australia, Hong Kong, New Zealand, Canada, South Africa, Greece, Portugal, Netherlands, Russian Federation and more
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemias

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.

Unknown

Prospective Observational Study of Pravafenix Cap

Dyslipidemias

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519

Dyslipidemia

Korea, Republic of
Sun Yat-sen University

Completed

The Effects of Dietary Supplement of Coenzyme Q10（CoQ10） on Dyslipidemia (TEDSCD)

Dyslipidemia

China
Hospital de Clinicas de Porto Alegre

Completed

Effects of Two Aquatic Training Models in Physiological Parameters of Elderly Dyslipidemic Women.

Dyslipidemias
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337

Dyslipidemia
Texas Christian University

Completed

The Effect of Meal Composition on Blood Lipids

Dyslipidemia

United States
NVP Healthcare

Completed

Compare the Pharmacokinetics of NVP-1205 and Coadministration of Rosuvastatin and Ezetimibe (NVP-1205)

Dyslipidemia

Korea, Republic of
Kowa Research Institute, Inc.

Completed

Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312

Dyslipidemia

United States
Chong Kun Dang Pharmaceutical

Completed

Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject.

Dyslipidemia

Korea, Republic of
Pronova BioPharma

Completed

The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects

Dyslipidemia

United States
The University of Hong Kong

Completed

The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS) (COME-PASS)

Dyslipidemia
Chong Kun Dang Pharmaceutical

Completed

Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 (CKD-519 FIH)

Dyslipidemia

Korea, Republic of
Kowa Research Institute, Inc.

Completed

A Thorough Corrected QT Interval Trial

Dyslipidemia

United States
University Health Network, Toronto

Completed

Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2

Dyslipidemia

Canada
Merck Sharp & Dohme LLC

Completed

A Long-term Study of ERN/LRPT (Extended Release Niacin/Laropiprant [MK0524A]) in Patients With Dyslipidemia (0524A-102)

Dyslipidemia
Fresenius Medical Care North America
Renal Research Institute

Completed

Phosphate Kinetic Modeling 2 (PKM2)

ESRD | Hyperphosphatemia

United States
Bayer

Completed

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Hyperphosphatemia | Dialysis

Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TA-8995 With Single, Escalating Doses in Healthy Subjects

Dyslipidemia

United Kingdom
D16 Pharma & Biotec Ltd.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh; Dhaka Medical... and other collaborators

Unknown

Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin (Cor16)

Dyslipidemia

Bangladesh
Takeda

Completed

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

Dyslipidemia

United States
Takeda

Completed

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

Dyslipidemia

United States, Germany, Argentina, Mexico, Poland, South Africa, Chile, Netherlands, Peru, Estonia, Russian Federation, Czech Republic, Hungary, Lithuania, Latvia, Slovakia, United Kingdom

3

Subscribe